 was 0.00 (0.00 to 0.00; *P* = 0.0000) for tanezumab 0 mg and 0.00 (0.00 to 0.00; *P* = 0.0000) for tanezumab 00 mg. At week 00, LS mean (00% CI) difference, vs tramadol, in LBPI was −0.00 (−0.00 to 0.00; *P* = 0.0000) for tanezumab 00 mg and −0.00 (−0.00 to 0.00; *P* = 0.0000) for tanezumab 0 mg.  